Home › Products › Oncology › Palbobuzz 125 Tablet
Palbobuzz 125 Tablet
Salt Composition: PALBOCICLIB
- Manufacturer: JASGUR LIFE SCIENCES LLP
- Pack Size: 21 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 125MG
- Prescription Required
- Storage: Keep Palbobuzz 125 Tablet out of sight and reach of children. Store at 20°C to 25°C.
₹2363.00₹6750.00
Inclusive of all taxes
Product Introduction
Palbobuzz 125 Tablet is a targeted therapy containing palbociclib, a cyclin-dependent kinase inhibitor used in anticancer treatment. It is indicated for hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic breast cancer, where cancer refers to uncontrolled and abnormal cell multiplication. The medication is administered in combination with other anticancer agents.
Common side effects associated with Palbobuzz 125 Tablet include nausea, vomiting, diarrhoea, tiredness, hair loss, dry skin, rash, infections, nosebleed, decreased appetite, low blood cell counts, swelling of lips and mouth, changes in taste, dry eye, blurred vision, and increased tearing. Inform your doctor if any of these side effects persist or cause concern.
Prior to treatment initiation, inform your healthcare provider if you have an allergy to Palbobuzz 125 Tablet or any of its ingredients. It is vital to disclose any existing conditions including signs of infections (fever, chills, or sore throat), liver disorders, kidney disorders, or intolerance to certain sugars. Consult your physician immediately if you experience dry cough, chest pain, or difficulty breathing, as these may indicate lung inflammation.
Provide your doctor with a complete list of all medications you are taking, including supplements and herbal medicines, before commencing treatment. Effective birth control measures should be used during treatment and for at least three weeks after the final dose. This medication is not recommended for children and adolescents under 18 years of age.
Uses
Palbobuzz 125 Tablet uses are Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.
How it works
Palbobuzz 125 Tablet works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.
How to Use
Take the Palbobuzz 125 Tablet exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this tablet as a whole with a glass of water. Avoid crushing, breaking, or chewing the tablet.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Palbobuzz 125 Tablet side effects are Serious: Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising) Lung inflammation (chest pain, dry cough, or difficulty breathing) Common: Tiredness Hair loss Dry skin, rash Infections Low blood cell counts. Decreased of appetite Nausea, vomiting
References
- Pfizer Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 26 Nov 2022], https://www.medicines.org.uk/emc/files/pil.4449.pdf
- Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
- Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
- Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029
Safety Advice
Pregnancy: Unsafe It is not recommended to take Palbobuzz 125 Tablet during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Lungs: Consult Your Doctor You need to tell your physician if you have any lung disorders before taking Palbobuzz 125 Tablet, as this medication should be used with caution in kidney disorders.
Breastfeeding: Consult Your Doctor It is not recommended to take Palbobuzz 125 Tablet while breastfeeding as it is not known whether it passes into the breast milk. consult your healthcare provider before taking this tablet.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.